Sandbox: DDx Kidney mass: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
* | * May have refractory hypertension, palpitations, headache, diaphoresis, anxiety, weight loss, and flank pain | ||
* MEN, von Hippel–Lindau disease, tuberous sclerosis, or neurofibromatosis | |||
* | |||
* | * Pallor | ||
* Tachycardia | |||
* | * Elevated serum catecholamines and metanephrines | ||
* | * Large, heterogeneous mass on CT | ||
* Areas of necrosis and cystic change | |||
* on CT | |||
* VHL, RET, NF1SDHB and SDHD gene mutation | |||
==Nonmalignant causes== | ==Nonmalignant causes== | ||
anaplastic sarcoma clear cell sarcoma mesoblastic nephroma metanephric stromal tumor nephroblastomatosis / nephrogenic rests neuroblastoma oncocytoid carcinoma after neuroblastoma ossifying | anaplastic sarcoma clear cell sarcoma mesoblastic nephroma metanephric stromal tumor nephroblastomatosis / nephrogenic rests neuroblastoma oncocytoid carcinoma after neuroblastoma ossifying | ||
Revision as of 16:51, 9 November 2015
- May have refractory hypertension, palpitations, headache, diaphoresis, anxiety, weight loss, and flank pain
- MEN, von Hippel–Lindau disease, tuberous sclerosis, or neurofibromatosis
- Pallor
- Tachycardia
- Elevated serum catecholamines and metanephrines
- Large, heterogeneous mass on CT
- Areas of necrosis and cystic change
- on CT
- VHL, RET, NF1SDHB and SDHD gene mutation
Nonmalignant causes
anaplastic sarcoma clear cell sarcoma mesoblastic nephroma metanephric stromal tumor nephroblastomatosis / nephrogenic rests neuroblastoma oncocytoid carcinoma after neuroblastoma ossifying